Track protection status across key markets to assess launch feasibility.
It is formulated by 1 pharmaceutical company such as ASTRAZENECA. It is marketed under 1 brand name, including LOKELMA. Available in 2 different strengths, such as 5GM/PACKET, 10GM/PACKET, and administered through 1 route including FOR SUSPENSION;ORAL.
API availability: Loading API feasibility...
Licensing: 1 potential partnersUS Launch window: Loading launch window...
Stay ahead with worldwide patent expiry and latest updates.
FDA approval history for this ingredient
Stay ahead with worldwide patent expiry insights, exclusivity data, and latest updates.
Key expiration dates for US patents covering this ingredient
Stay ahead with worldwide patent expiry insights, market data, and research updates.
Latest drug strengths approved by FDA
Strength | Route of Administration | Companies | Latest Approval Date |
---|
Patents approved by the FDA for the ingredient
|
Patent Number | Publication Date | Legal Status | Patent Expiry Date | |
---|---|---|---|---|---|
{"application_id":"35401","ingredient":"SODIUM ZIRCONIUM CYCLOSILICATE","trade_name":"LOKELMA","family_id":"5c81cb3934d44010abf1","publication_number":"US8808750B2","cleaned_patent_number":"8808750","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-02-10","publication_date":"2014-08-19","legal_status":"Granted"} | US8808750B2 | 19 Aug, 2014 | Granted | 10 Feb, 2032 | |
{"application_id":"35396","ingredient":"SODIUM ZIRCONIUM CYCLOSILICATE","trade_name":"LOKELMA","family_id":"5c81cb3934d44010abf1","publication_number":"US10398730B2","cleaned_patent_number":"10398730","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-02-10","publication_date":"2019-09-03","legal_status":"Granted"} | US10398730B2 | 03 Sep, 2019 | Granted | 10 Feb, 2032 | |
{"application_id":"35403","ingredient":"SODIUM ZIRCONIUM CYCLOSILICATE","trade_name":"LOKELMA","family_id":"5c81cb3934d44010abf1","publication_number":"US9844567B2","cleaned_patent_number":"9844567","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-02-10","publication_date":"2017-12-19","legal_status":"Granted"} | US9844567B2 | 19 Dec, 2017 | Granted | 10 Feb, 2032 | |
{"application_id":"6606","ingredient":"SODIUM ZIRCONIUM CYCLOSILICATE","trade_name":"LOKELMA","family_id":"5c81cb3934d44010abf1","publication_number":"US10413569B2","cleaned_patent_number":"10413569","drug_product_flag":"-","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-02-10","publication_date":"2019-09-17","legal_status":"Granted"} | US10413569B2 Molecular | 17 Sep, 2019 | Granted | 10 Feb, 2032 | |
{"application_id":"35405","ingredient":"SODIUM ZIRCONIUM CYCLOSILICATE","trade_name":"LOKELMA","family_id":"5c81cb3934d44010abf1","publication_number":"US10335432B2","cleaned_patent_number":"10335432","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-02-10","publication_date":"2019-07-02","legal_status":"Granted"} | US10335432B2 | 02 Jul, 2019 | Granted | 10 Feb, 2032 | |
{"application_id":"35397","ingredient":"SODIUM ZIRCONIUM CYCLOSILICATE","trade_name":"LOKELMA","family_id":"5c81cb3934d44010abf1","publication_number":"US11406662B2","cleaned_patent_number":"11406662","drug_product_flag":"-","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-02-10","publication_date":"2022-08-09","legal_status":"Granted"} | US11406662B2 Molecular | 09 Aug, 2022 | Granted | 10 Feb, 2032 | |
{"application_id":"35404","ingredient":"SODIUM ZIRCONIUM CYCLOSILICATE","trade_name":"LOKELMA","family_id":"5c81cb3934d44010abf1","publication_number":"US9861658B2","cleaned_patent_number":"9861658","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-02-10","publication_date":"2018-01-09","legal_status":"Granted"} | US9861658B2 | 09 Jan, 2018 | Granted | 10 Feb, 2032 | |
{"application_id":"35400","ingredient":"SODIUM ZIRCONIUM CYCLOSILICATE","trade_name":"LOKELMA","family_id":"5c81cb3934d44010abf1","publication_number":"US8802152B2","cleaned_patent_number":"8802152","drug_product_flag":"-","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-04-19","publication_date":"2014-08-12","legal_status":"Granted"} | US8802152B2 Molecular | 12 Aug, 2014 | Granted | 19 Apr, 2032 | |
{"application_id":"37037","ingredient":"SODIUM ZIRCONIUM CYCLOSILICATE","trade_name":"LOKELMA","family_id":"7447e6e201524b83b403","publication_number":"US9913860B2","cleaned_patent_number":"9913860","drug_product_flag":"-","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2033-10-22","publication_date":"2018-03-13","legal_status":"Granted"} | US9913860B2 Molecular | 13 Mar, 2018 | Granted | 22 Oct, 2033 | |
{"application_id":"7398","ingredient":"SODIUM ZIRCONIUM CYCLOSILICATE","trade_name":"LOKELMA","family_id":"7447e6e201524b83b403","publication_number":"US10695365B2","cleaned_patent_number":"10695365","drug_product_flag":"-","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2033-10-22","publication_date":"2020-06-30","legal_status":"Granted"} | US10695365B2 Molecular | 30 Jun, 2020 | Granted | 22 Oct, 2033 | |
{"application_id":"37036","ingredient":"SODIUM ZIRCONIUM CYCLOSILICATE","trade_name":"LOKELMA","family_id":"7447e6e201524b83b403","publication_number":"US8877255B2","cleaned_patent_number":"8877255","drug_product_flag":"-","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2033-10-22","publication_date":"2014-11-04","legal_status":"Granted"} | US8877255B2 Molecular | 04 Nov, 2014 | Granted | 22 Oct, 2033 | |
{"application_id":"28467","ingredient":"SODIUM ZIRCONIUM CYCLOSILICATE","trade_name":"LOKELMA","family_id":"f160d8a7d285477cb6a2","publication_number":"US9592253B1","cleaned_patent_number":"9592253","drug_product_flag":"-","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-10-14","publication_date":"2017-03-14","legal_status":"Granted"} | US9592253B2 Molecular | 14 Mar, 2017 | Granted | 14 Oct, 2035 | |
{"application_id":"37267","ingredient":"SODIUM ZIRCONIUM CYCLOSILICATE","trade_name":"LOKELMA","family_id":"f160d8a7d285477cb6a2","publication_number":"US11738044B2","cleaned_patent_number":"11738044","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-10-14","publication_date":"2023-08-29","legal_status":"Granted"} | US11738044B2 | 29 Aug, 2023 | Granted | 14 Oct, 2035 | |
{"application_id":"37268","ingredient":"SODIUM ZIRCONIUM CYCLOSILICATE","trade_name":"LOKELMA","family_id":"f160d8a7d285477cb6a2","publication_number":"US10300087B2","cleaned_patent_number":"10300087","drug_product_flag":"-","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-10-14","publication_date":"2019-05-28","legal_status":"Granted"} | US10300087B2 Molecular | 28 May, 2019 | Granted | 14 Oct, 2035 |
Latest clinical trials and research studies for this ingredient
NCT ID | Title | Status | Phase | Conditions | Start Date | Completion Date |
---|
Manufacturing Locations
Unlock access to all suppliers of Sodium Zirconium Cyclosilicate
Note: Patent expirations and exclusivity timelines are dynamic and may shift based on litigation, regulatory extensions, and maintenance filings. Regular monitoring is advised.